Who owns Professor Thomas William Rademacher?

No ownership or control links for Professor Thomas William Rademacher are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Professor Thomas William Rademacher's risk level?

WhiteIntel flags Professor Thomas William Rademacher as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Professor Thomas William Rademacher appear across sources?

Professor Thomas William Rademacher is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

PersonLow

Professor Thomas William Rademacher

Name: Professor Thomas William Rademacher — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Professor Thomas William Rademacher, Person, US

Professor Thomas William Rademacher — US person (oo-person:GB-COH-PER-09955881-JViG9vim1Ca7dkT-ScT__ozwrrg). 1 holding. Cited to 1 registry.

controls 1 company

Ownership graph Export .md

JSON / MCPsample

The finding

Controls or directs 1 company in the resolved graph.

Investigative lead by resolved identity, not a legal determination.

/01

Registry identity

Controls: 1 company
Risk: Low
Jurisdiction: US

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies

Professor Thomas William Rademacher
- GYLDEN PHARMA LIMITED· beneficial owner· via OpenOwnership

Nothing further is withheld here. The ownership and control links above are everything we have resolved for Professor Thomas William Rademacher — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of Professor Thomas William Rademacher is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, nationality & aliases
Sanctions, PEP & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on Professor Thomas William Rademacher is behind a paywall — everything we hold on this subject is already on this page.

/03

People & control

1 party · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
GYLDEN PHARMA LIMITED
Also holds roles at 2 other companies
- GYLDEN LIMITEDbeneficial owner
- Professor Thomas William Rademacherbeneficial owner

1 party · 0 current. Ceased and resigned records are retained as history.

/04

Common questions

Who owns Professor Thomas William Rademacher?: No ownership or control links for Professor Thomas William Rademacher are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is Professor Thomas William Rademacher's risk level?: WhiteIntel flags Professor Thomas William Rademacher as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Professor Thomas William Rademacher appear across sources?: Professor Thomas William Rademacher is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Professor Thomas William Rademacher. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…